Fecal Microbiota Transplantation Clinical Trial
Official title:
Efficacy and Safety of Fecal Microbiota Transplantation in Patients With Intestinal Dysbiosis -A Pilot Study
In recent years, researches illustrate that multifactorial diseases such as functional gastrointestinal disorders, autoimmune diseases, metabolic, behavioral and neurological diseases are associated with an abnormal microbiome structure-dysbiosis, which means the imbalance of the microbiome community. Fecal microbiota transplantation (FMT), the infusion of faeces from a healthy donor to the gastrointestinal tract of a recipient patient aiming to alter the intestine microbiota, is recommended to be performed in Clostridium difficile infection(CDI) as the most effective therapy. It also being used experimentally in the treatment of the disease states linked to dysbiosis of the intestinal microbiota. However, the efficacy and safety of FMT to treat the dysbiosis-associated diseases is still in its infancy. To further verify the indications above, more data is required to be collected through studies.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Enrolling by invitation |
NCT04436874 -
Fecal Microbiota Transplantation in the Treatment of Inflammatory Bowel Disease
|
N/A | |
Recruiting |
NCT03325855 -
Fecal Microbiota Transplant National Registry
|
||
Completed |
NCT06162702 -
Clinical Study of Fecal Microbiota Transplantation in the Treatment of Small Intestinal Bacterial Overgrowth (SIBO)
|
N/A | |
Active, not recruiting |
NCT05607745 -
Dietary Counseling Coupled With FMT in the Treatment of Obesity and NAFLD - the DIFTOB Study
|
N/A | |
Completed |
NCT05121285 -
Distribution of FMT After Delivery by · Lower GI Endoscopy vs Enema With and Without Positioning of the Patient
|
N/A | |
Active, not recruiting |
NCT05917379 -
The Safety and Efficacy of FMT in Patients With CID
|
Phase 1/Phase 2 | |
Recruiting |
NCT02318147 -
Fecal Microbiota Transplantation for Pancreatitis With Infectious Complications(FMTPIC)
|
Phase 1 | |
Completed |
NCT02318134 -
Fecal Microbiota Transplantation for Pancreatitis
|
Phase 2 | |
Completed |
NCT05035784 -
RCE With FMT in the Treatment of Childhood Constipation
|
N/A | |
Active, not recruiting |
NCT04173208 -
Main Trial of the Cesarean Section and Intestinal Flora of the Newborn Study
|
N/A | |
Terminated |
NCT04577729 -
The IRMI-FMT Trial
|
N/A | |
Not yet recruiting |
NCT02435160 -
The Study of Efficacy and Mechanism in Fecal Microbiota Transplantation in the Treatment of Ulcerative Colitis
|
Phase 2/Phase 3 | |
Recruiting |
NCT04837313 -
Efficacy and Safety of Fecal Microbiota Transplantation in the Treatment of Parkinson's Disease With Constipation
|
N/A | |
Recruiting |
NCT04861649 -
Metabonomics of COPD and Transplanting of Faecal Bacteria in the Treatment of Its Malnutrition
|
N/A | |
Withdrawn |
NCT04078581 -
Profiling Fecal Samples for Selection of Donors of Feces
|
N/A | |
Recruiting |
NCT05821010 -
Synbiotics and Fecal Microbiota Transplantation to Treat Non-Alcoholic Steatohepatitis
|
Phase 2 | |
Recruiting |
NCT05273255 -
Fecal Microbiota Transplantation in Patients With Malignancies Not Responding to Cancer Immunotherapy
|
N/A | |
Not yet recruiting |
NCT05253222 -
Methodology and Clinical Value of RIT in Intestinal Obstructive Diseases Mediated by Colonic TET
|
N/A | |
Recruiting |
NCT04285424 -
FMT for Steroid Resistant Gut Acute GVHD
|
Early Phase 1 | |
Withdrawn |
NCT03527056 -
Pilot Study Using Oral Capsule FMT to Decolonize GI CRE
|
Early Phase 1 |